Packaging & Labelling

A blister pack may seem like a simple enough concept until you’re trying to prove that it will open cleanly every time. Peel testing turns each peel into data so you can protect dose integrity, support and child resistance...

The pharmaceutical industry is increasingly moving toward a more holistic approach to quality control by combining various inspection technologies into a single, unified platform. Integrated inspection systems for leak detection in pharma offer a multi-faceted solution that simultaneously addresses cosmetic defects, particulate contamination, and container closure integrity. By merging high-speed visual cameras with sensitive high-voltage leak detection modules, these systems provide a comprehensive assessment of every unit, ensuring that each dose of medication is contained within a perfectly sealed and sterile environment. This integration not only reduces the risk of secondary contamination but also significantly improves the overall efficiency and reliability of the manufacturing process.

Maintaining the highest standards of pharmaceutical quality is a fundamental requirement for the safe delivery of injectable medications. The development of advancing pharma quality with HV leak detection tools represents a major leap forward in the deterministic testing of container closure integrity. By utilizing sophisticated sensors and high-voltage electrical fields, these tools can detect microscopic structural defects that would otherwise compromise the sterility of life-saving products. This high-sensitivity approach significantly enhances the accuracy of the inspection process, providing manufacturers with a robust solution for ensuring packaging integrity and regulatory compliance.

The Shift Toward Sustainable Ingredients One of the most significant transformations in the nutraceutical sector is the shift toward eco-friendly and responsibly sourced ingredients. Marine-Based Nutraceuticals Marine-derived ingredients such as seaweed, algae, and bioactive compounds are gaining traction due to their high efficacy...

SGD Pharma has entered into a Franco-American OEM collaboration with Prince Sterilization Services, LLC to validate Ready-to-Use (RTU) Type I glass primary packaging solutions for the North American market. As the first outcome of this partnership, the companies have...

PFAS regulations in pharmaceutical supply chains are reshaping how critical materials are sourced, validated, and justified amid rising environmental scrutiny. Manufacturers must balance sustainability, regulatory compliance, and material performance to ensure uninterrupted delivery of safe and effective medicines.

Accessing comprehensive global drug databases streamlines the drug development process, allowing researchers to utilize existing clinical data and regulatory benchmarks to shorten innovation cycles.